Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults

NCT01574638 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

NIH

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: Rifapentine (RPT)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)